Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- ELVT -15.2%, EXPE -15.1%, WEB -12%, ZG -9.2%, CBL -8.6%, LGF.A -6.9%, AQ -6.5%,SWIR -4.1%, VCRA -4%, HNI -3.3%, CBOE -2.9%, HOLI -1.9%, HDP -1.8%, VSAT -1.1%
Select EXPE peers showing weakness:
- PCLN -3.3%, TRIP -1.4%
Other news:
- TNDM -24.7% (files Form S-1MEF for potential $11.5 mln offering of common stock),WWD -9.9% (Woodward says not in discussions with Boeing (BA) over a possible acquisition of Woodward), MGEN -5.2% (prices 7 mln share common stock offering at $5.50 per share), IMGN -4.1% (to implement new operating model, will result in a net reduction of the co's workforce by approximately 20 positions by the end of 2018),CEMI -3.9% (commences underwritten registered public offering of common stock, won a three-year tender from the Ethiopia Pharmaceuticals Fund and Supply Agency to deliver its HIV 1/2 STAT-PAK Assay with total contract value of $15.8 mln; sees 2017 revs $23.7-24 mln vs $23.8 mln est), CEMI -3.9% (announces pricing of its public offering), HMNY -2.9% (stockholders approved an amendment to the Company's Certificate of Incorporation to increase the number of shares of authorized common stock to 500 mln from 100 mln shares), PACB -1.2% ( receives unfavorable outcome in first phase of patent litigation against Oxford Nanopore), .
Analyst comments:
- DDD -1.7% (downgraded to Underweight from Neutral at JP Morgan)
- WYNN -1.9% (downgraded to Equal-Weight from Overweight at Morgan Stanley)